The 6th International Annual Congress on Controversies on Cannabis-based Medicines (MED CANNABIS 2026)

The 6th International Annual Congress on Controversies on Cannabis-based Medicines (MED CANNABIS 2026) is a key event for the medical cannabis community. It brings together experts from around the world to discuss the latest research, clinical trials, and therapeutic applications of cannabis. The congress aims to address the controversies and challenges in the field, fostering a science-driven dialogue on the future of cannabis-based medicines.

Who Should Attend

This congress is designed for healthcare professionals, including physicians, pharmacists, and nurses, as well as researchers, scientists, and policymakers. It is also relevant for professionals from the pharmaceutical and biotech industries who are involved in the development and commercialization of cannabis-based treatments.

What to Expect

The event will feature a comprehensive program of keynote lectures, panel discussions, and abstract presentations. Attendees can expect to learn about the latest scientific advancements, engage in debates on controversial topics, and network with leading experts in the field. The congress will cover a wide range of topics, from basic science to clinical practice.

History

As the 6th edition, this congress builds on a successful series of events that have become a premier platform for the discussion of cannabis-based medicines. Organized by Bioevents, the congress has grown in prominence, attracting a global audience and contributing to the advancement of medical cannabis knowledge. The choice of Krakow, Poland, for the 2026 edition highlights the increasing interest in medical cannabis across Europe.